baber/WOPTO huggingface dataset:
Patent NZ-515980-A (NZ)
Title: High performance data cable
Inventor: GAREIS GALEN M
IPC: H01B11/10
Filed: 2000-06-14
Abstract: A high performance twisted pair data cable (20) that has an adjusted to 20 degrees Celsius impedance standard deviation of less than 3.5 when the standard deviation is calculated around an average impedance of 50 to 200 ohms and preferably 90 to 110 ohms. The twisted pair is helically wrapped with a metal shield tape (16) at a tension that provides a cross-sectional void of less than 25 % and preferably less than 18 % of the cross-sectional area of the shielded twisted pair cable. The tape is helically wrapped with an overlap of 30-45 % and at an angle of 35-45 degrees with respect to the longitudinal axis of the cable. The cable has a rating up to 600 MHz. The shield wrapping tape is a metal tape, a composite tape having a metal layer on a non-metal base, or a composite tape having a non-metal base and a metal layer on both sides of the base.
Patent NZ-529426-A (NZ)
Title: Spiroazabicyclic heterocyclic amine ligands for nicotinic acetylcholine receptors useful in therapy
Inventor: PHILLIPS EIFION
IPC: C07D491/22
Filed: 2002-05-29
Abstract: Spiroazabicyclic heterocyclic amine ligands for nicotinic acetylcholine receptors of formula (I), their pharmaceutically acceptable salts and their use in therapy is disclosed. These compounds are suitable for use in the treatment and prophylaxis of psychotic disorders or intellectual impairment disorders or diseases or conditions in which activation of a7 nicotinic receptor is beneficial.
Patent NZ-534708-A (NZ)
Title: Polyalkylene glycol with moiety for conjugating biologically active compound
Inventor: LIN KOCHUNG
IPC: A61K47/48
Filed: 2003-01-17
Abstract: Disclosed are polyalkylene glycol compounds with a moiety for the binding of biologically active compounds. Also disclosed is the use of the disclosed compounds when conjugated with biologically active compounds for the treatment of viral infections (especially hepatitis C) and multiple sclerosis.
Patent NZ-538001-A (NZ)
Title: Immunostimulatory nucleic acids
Inventor: KRIEG ARTHUR M
IPC: C12Q1/68
Filed: 2003-08-19
Abstract: Disclosed is an oligonucleotide comprising: 5'T*C_G(N6C_GN7)2-3T*C_G*T*T3'(SEQ ID NOs:311-312) wherein N6 and N7 are independently between 1 and 5 nucleotides in length, wherein * refers to the presence of a stabilized internucleotide linkage, and wherein _ refers to the presence of a phosphodiester internucleotide linkage and wherein the oligonucleotide has a length of 16-40 nucleotides. Also disclosed is the use of the oligonucleotide for stimulating or modulating immune responses.
Patent NZ-538943-A (NZ)
Title: Pyridine derivatives as CB2 cannabinoid receptor modulators
Inventor: EATHERTON ANDREW JOHN
IPC: A61P29/00
Filed: 2003-09-25
Abstract: Pyridine derivatives of formula (I) and pharmaceutical compositions containing these compounds are disclosed, wherein the variables are as defined in the specification. These compounds and pharmaceutical compositions are suitable for treating pain and diseases that are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor CB2.
Patent NZ-542425-A (NZ)
Title: A method and device for distribution of a fluid
Inventor: NEUMANN CHRISTIAN
IPC: A61J1/20
Filed: 2004-03-05
Abstract: A method and device for distributing a fluid are disclosed. A valve (1) has multiple inlets and outlets and is equipped with a check valve. Connected to the valve are: a fluid sampling and injecting device, such as a syringe (2); a gas (e.g. air) supply conduit; a supply conduit for the liquid to be distributed; and a discharge conduit (6). The method consists of drawing in the liquid to be distributed in order to transfer it to the sampling and injecting device (2), injecting the liquid into the discharge conduit (6), drawing off the gas in order to transfer it into the sampling and injecting device (2), and injecting the gas into the discharge conduit (6) in order to push the remaining liquid into the discharge conduit (6).
Patent NZ-544161-A (NZ)
Title: Method of marking a product, marked product resulting thereof, and method of identifying same
Inventor: TILLER THOMAS
IPC: G01N33/14
Filed: 2004-05-19
Abstract: Disclosed is a method for marking a bulk material, destined to human application, the method comprising the steps of: a) identifying at least one ion comprised in the said material at a concentration level of below 50 ppm in the unmarked state; b) selecting a marking composition comprising at least one ion as identified in step a), from the groups of ions being comprised in standard sea water; c) incorporating the marking composition of step b) into the said unmarked material; wherein the concentration level of the said at least one ion in the marked material is increased in step c) by at least the factor of 3, as compared to the concentration level of the ion present in the unmarked material.
Patent NZ-545518-A (NZ)
Title: Vehicle suspension systems for reducing or eliminating a squat response
Inventor: WEAGLE DAVID
IPC: B62K1/00
Filed: 2004-09-24
Abstract: A suspension system for a driven wheel suspension is disclosed. The suspension system comprises a damper unit, a pivot, and a suspended wheel. The suspension system is designed to result in a squat curve (17) with a negative slope in the beginning of suspension travel, in the interim of suspension travel and in the end of suspension travel. The slope in the beginning of suspension travel and in the end of suspension travel is more negative than the slope in the interim of suspension travel.
Patent NZ-545578-A (NZ)
Title: Gamma-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
Inventor: HORVATH STEPHANE
Filed: 2006-02-27
Abstract: Disclosed is a gamma-crystalline form of ivabradine hydrochloride of formula (I) characterised by the powder X-ray diffraction diagram as described in the specification. Also disclosed are processes for the preparation of said crystalline form; pharmaceutical compositions containing said crystalline form; and the use of said crystalline form as a bradycardic, in particular for the treatment of various clinical situations of myocardial ischaemia.
Patent NZ-551602-A (NZ)
Title: Amido compounds and their use as pharmaceuticals
Inventor: YAO WENQING
IPC: A61K31/495
Filed: 2005-06-23
Abstract: Disclosed are inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1, antagonists of the mineralocorticoid receptor (MR), and pharmaceutical compositions thereof. The compounds have formulae IIIa and IIIb, wherein Cy is optionally substituted aryl or heteroaryl, R1 and R2 are optionally substituted alkyl, and the remaining substituents are as defined in the specification. The compounds can be useful in the treatment of various diseases associated with expression or activity of 11-beta hydroxyl steroid dehydrogenase type I and/or diseases associated with aldosterone excess.
Patent NZ-554780-A (NZ)
Title: Spectrophotometer
Inventor: JUHL HENRIK VILSTRUP
IPC: G01N21/03
Filed: 2005-12-01
Abstract: A spectrophotometer is provided, including a sample holder adapted to present internally several different path lengths to radiation of several wavelengths emitted from a source; a detection arrangement for detecting a wavelength dependent intensity of emitted radiation after it has traversed one of the path lengths and for providing an output indicative thereof; and an arithmetic unit operably connected to receive the output and to generate therefrom one or both a quantitative and a qualitative indication of a substance of interest within a sample. The arithmetic unit is adapted to calculate a value dependent on the ratio of received outputs at two of the different path lengths for a same one of the emitted wavelengths and to generate by means of a multivariate statistical analysis of the calculated value at each of the wavelengths one or both the quantitative and the qualitative indications.
Patent NZ-562269-A (NZ)
Title: In vitro method for simultaneously detecting and identifying antibiotics of different classes and corresponding diagnostic kit
Inventor: GRANIER BENOIT
IPC: G01N33/558
Filed: 2006-04-13
Abstract: Disclosed is a diagnostic kit for the simultaneous measurement of antibiotics of different classes, comprising: - a single reactive mixture comprising at least two receptors, a first receptor specific for the recognition of â-lactames and a second receptor to specifically and competitively recognise a tetracycline and a biotinylated fragment of nucleic acid, both receptors being marked, either directly or indirectly by means of an antibody or of an antibody in association with protein A, said mixture comprising also the biotinylated fragment of nucleic acid; - a recovery system in the form of a solid support comprising a nitrocellulose membrane on which are attached at two known and distinct sections, called test zones, an antibiotic with a â-lactame core and an avidine, respectively or vice versa; in such a way that the marking intensity detected on the recovery system in both test zones independently results from the competitive recognition of each antibiotic by its marked receptor. Preferably, the receptors are marked with particles of colloidal gold.
Patent NZ-564762-A (NZ)
Title: Compositions and methods for the treatment or prevention of chemoresistant neoplasia
Inventor: BISWAL SHYAM
IPC: A61K48/00
Filed: 2006-05-26
Abstract: Provided is a method for diagnosing a subject as having or having a propensity to develop cancer chemoresistance, the method comprising detecting in a biological sample of the subject a specified mutation in Keap1 gene and detecting an increase in the expression of Nrf2, GSH, GST, and/or NQO1 marker molecules relative to the expression of Nrf2, GSH, GST, and NQO1 markers in a normal tissue, thereby diagnosing the subject as having or having a propensity to develop chemoresistance. The cancer may be non-small cell lung cancer.
Patent NZ-568267-A (NZ)
Title: Wringing device, for flexible container, with nip shafts and take-up shaft
Inventor: RUSSO JOSEPH R
IPC: B30B3/04
Filed: 2006-05-01
Abstract: A wringing device is disclosed for expelling materials from a flexible container. In at least one embodiment, the wringing device may be used to expel fluids from a flexible container contained within an intermediate bulk container (IBC). The wringing device may be formed from a support frame and a carriage movably coupled to the support frame for supporting components of the wringing device. The wringing device may include a nip shaft coupled to the carriage and a movable nip shaft movably coupled to the carriage proximate to the nip shaft. The movable nip shaft may be biased toward the nip shaft with a biasing device. The wringing device may include one or more drive devices for driving a take-up shaft, a wringing device transport system, or the carriage, or any combination thereof.; The wringing device may also include a transport vehicle for transporting the wringing device between different intermediate bulk containers.
Patent NZ-571688-A (NZ)
Title: Excavator with resilient contact with the ground to inhibit unwanted movement during excavation using a cutter and bucket
Inventor: THOMAS GARETH JOHN
IPC: E02F9/16
Filed: 2007-03-01
Abstract: Disclosed is an excavator (1) which can contact the ground to inhibit unwanted movement. The excavator comprises: an excavator main body; an apron (2) located at or in proximity to the front of the main body for the receipt of excavated material; and a conveyor (3). The conveyor extends from the apron to the rear of the main body and moves excavated material from the front to the rear of the main body. The excavator further comprises an arm (11) with an attachment (5) having a cutter portion (5a) and a bucket portion (5b) for excavating material and moving the excavating material towards the apron. The excavator also has a support associated with the front of the main body, the support movable from a first position in which the support is in resilient contact with the ground to a second position in which there is substantially no contact between the support and the ground. The support comprises one or both of the apron and conveyor.
Patent NZ-575829-A (NZ)
Title: Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein
Inventor: OKSENBERG DAVID A
IPC: C12Q1/68
Filed: 2007-08-30
Abstract: Disclosed is an isolated non-naturally occurring nucleic acid sequence that binds to a target molecule accessible from the surface of a mammalian sperm cell comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS: 3-35. Further disclosed are methods of separating a mixture of mammalian sperm cells by contacting a mixture of sperm cells with a composition comprising at least one nucleic acid as described above.
Patent NZ-578274-A (NZ)
Title: CV joint boot manufactured directly onto driveshaft
Inventor: COLLINGTON READ DANIEL
IPC: B29C45/00
Filed: 2009-09-16
Abstract: A method of manufacturing/installing a CV joint boot on a vehicle driveshaft by assembly of a mould directly on the driveshaft. The mould comprises a mould core (3) in two halves and a mould shell (2) in two halves, a bore being provided through the assembled mould's centre to accommodate the driveshaft, the mould also providing a cavity (1) with the shape of the required CV joint boot. Fluid rubber is injected into the cavity to provide, when cured, a CV joint boot located on the driveshaft. The mould is removed and can be used again.
Patent NZ-589335-A (NZ)
Title: Metering of powder for colouring of moulded plastics
Inventor: BACK SEUNG HOON
IPC: B29C31/06
Filed: 2006-05-17
Abstract: A powder supply metering apparatus includes a driving part 32, a powder supply part 40 connected to the driving part and transferring the powder along a predetermined path when driven by the driving part. A chamber is placed on the sides of the powder supply part and receives the transferred powder, and a compression part compresses the powder within the chamber. A quantitative supply part separates a measured amount of powder from the compressed powder and discharges 48c the separated powder from the chamber. The driving part may be a gear box driven by a motor and having a plurality of output drive shafts. The powder supply part may include a powder reservoir 40 and a powder pushing unit 60, 48b to transfer the powder from the reservoir into the chamber.
Patent NZ-591370-A (NZ)
Title: Cylinder shaped heterogenous catalyst units with high domed ends and exterior flutes
Inventor: CAIRNS DANIEL LEE
IPC: B01J35/02
Filed: 2009-08-24
Abstract: A cylindrical catalyst unit has a length C and diameter D, has two or more flutes running along the length of the exterior cylindrical surface, and domed ends of lengths (heights) A and B. The shape is constrained so that (A+B+C)/D is in the range 0.50 to 2.00, and (A+B)/C is in the range 0.40 to 5.00. The dome heights A and B may be equal. The catalyst may be used particularly in reactions where hydrogen is a reactant such as hydroprocessing, hydrogenation, water-gas shift reactions, methanation, hydrocarbon synthesis by the Fischer-Tropsch reaction, methanol synthesis and ammonia synthesis.
Patent NZ-592378-A (NZ)
Title: Choline and tromethamine salt of licofelone
Inventor: ALBRECHT WOLFGANG
IPC: A61K31/407
Filed: 2009-10-30
Abstract: Disclosed is the choline (formula (I) salt of licofelone also known as 6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-ylacetic acid choline. Also disclosed is a pharmaceutical composition comprising one of the salts and the use of one of the salts for the manufacture of a medicament for treating rheumatoid diseases.
Patent NZ-593127-A (NZ)
Title: A pressure sensitive adhesive and a pressure sensitive adhesive tape
Inventor: MINO YASUHIRO
IPC: C09J7/26
Filed: 2009-11-24
Abstract: 593127 Disclosed is a pressure sensitive adhesive obtained by polymerizing a mixture containing: 1) 100 mass parts of (meth)acrylic monomer comprising: 98-50 mass parts of a first monomer selected from an aliphatic (meth)alkyl acrylate having a carbon number of 4-6 and an aliphatic (meth)alkyl acrylate having a carbon number of7-12, wherein the glass transition temperature ofa homo-polymer thereof is -25 degrees C or less; and 2-50 mass parts of a second monomer comprising one or more selected from the group consisting of: an amide group-containing ethylenic unsaturated copolymerizing monomer, a carboxylic group-containing ethylenic unsaturated copolymerizing monomer, an amino group-containing ethylenic unsaturated copolymerizing monomer, a non-tertial alkyl(meth)acrylate wherein the glass transition temperature of a homo-polymer thereof is -25 degrees C or more, and a monomer represented by the chemical structural formula: CH2=CR1COO(R2O)nR3 or CH2=CR1COOR4R5 where the variables are as defined in the specification 2) 10-100 mass parts of a block copolymer; 3) 20-100 mass parts of hydrogenated tackifier; and 4) 0.05-1.0 mass parts of a photopolymerization initiator. Also disclosed is an adhesive tape comprising a substrate layer and a pressure sensitive layer comprising the adhesive.
Patent NZ-595221-A (NZ)
Title: Sand erosion prevention and regain structure for beaches
Inventor: SPRY WILLIAM J
IPC: E02B3/04
Filed: 2006-05-19
Abstract: A beach erosion control system for removing sand from incoming water. The control system includes a plurality of generally horizontally oriented, vertically spaced separation units (120, 124, 126, 128, 131), each of the units having a wave-deflecting ramp (142) for receiving the sand containing water thereover, a plurality of elongated, generally vertically oriented, relatively spaced barrier plates (144) oriented generally parallel to each other and spaced from the wave deflection ramp in a direction of propagation of a wave of the incoming water across each of the units, a plurality of elongated slots (160, 162, 164) for facilitating downward transfer of sand, and at least one anchor (190) for securing each of the units to the sand.
Patent NZ-596688-A (NZ)
Title: Anchor cage installation method
Inventor: ZHU HONGBING
IPC: E02D27/00
Filed: 2011-11-25
Abstract: 596688 An installing method for an anchor cage, comprises the steps of providing an anchor flange, where a plurality of first bolt holes are dispersedly arranged on the anchor flange along a circumferential direction and the first bolt holes comprise a first group of bolt holes and a second group of bolt holes, providing a template flange where a plurality of bolt holes are arranged on the template flange along a circumferential direction and the plurality of bolt holes comprise a first group of bolt holes and a second group of bolt holes. And a shimming flange. The first group of bolt holes of the template flange correspond to the first group of bolt holes of the anchor flange, and the second group of bolt holes of the template flange correspond to second bolt holes of the anchor flange. The shimming flange has a plurality of bolt holes arranged along a circumferential direction, and the bolt holes correspond to the first and second groups of bolt holes of the anchor flange. The lower ends of a first group of anchor bolts are assembled and fixed in the first group of bolt holes of the anchor flange, and the upper ends are assembled in the first group of bolt holes of the template flange. After a second group of anchor bolts are penetrated through the second group of bolt holes of the anchor flange and the second group of bolt holes of the template flange all the anchor bolts are adjusted and fixed. Reinforcing steel bars are then bound and concrete poured below the template flange to form a reinforced concrete platform. The template flange is then taken down and the upper ends of all the anchor bolts are assembled in the corresponding bolt holes of the shimming flange.
Patent NZ-597976-A (NZ)
Title: Composition comprising neurogenic CNS lipids, arginine, lysine, leucine, chromium, tin, selenium, strontium, vanadium, wolfram and folic acid for treating sterile inflammation
Inventor: TALLBERG THOMAS
IPC: A61K33/24
Filed: 2008-12-17
Abstract: Disclosed is the use of a) neurogenic CNS lipids b) L-amino acids arginine (Arg) or lysine (Lys) and leucine (Leu), c) trace elements chromium (Cr), tin (Sn), selenium (Se), strontium (Sr), vanadium (V), and tungsten (W), and d) folic acid for the manufacture of a pharmaceutical composition for treating or preventing sterile inflammation causing Crohn's disease.
Patent NZ-599156-A (NZ)
Title: Tracking system
Inventor: INGERSON DAVID CRAIG
IPC: H04W4/029
Filed: 2010-09-24
Abstract: Disclosed is a tracking system for tracking the location of an individual. The tracking system includes a tracking device (100) worn by the individual in use, the tracking device (100) including a device processor (121). The processor (121) determines a tracking device location and transfers location information indicative of the tracking device location to a base station via a communications network (140). The base station includes a base station processor that receives the location information from the tracking device (100), generates a location indication indicative of the tracking device location using the location information, and, provides the location indication to at least one user via a user end station and a communications network. The location information includes address information
Patent NZ-600920-A (NZ)
Title: Compositions and methods for using cells to treat heart tissue
Inventor: TERZIC ANDRE
IPC: A61K35/28
Filed: 2009-05-20
Abstract: 600920 Disclosed is the use of a composition comprising TGFp-1, BMP4, a-thrombin, Cardiotrophin, and Cardiogenol C in manufacture of a medicament for the treatment of ischemic cardiomyopathy, myocardial infarction, or heart failure. Further disclosed is the use of a population of cells guided towards cardiopoiesis in the manufacture of a medicament for treatment of ischemic cardiomyopathy, myocardial infarction, or heart failure in a mammal, wherein the population of cells guided towards cardiopoiesis are obtained by a method comprising (i) culturing initial cells in the presence of a composition comprising TGF?-1, BMP4, ?-thrombin, Cardiotrophin, and Cardiogenol C and (ii) determining that a sample of cells from a population of cells guided towards cardiopoiesis comprises cells that express an elevated level of at least one of the mRNA selected from the group consisting of MEF2c mRNA, MESP-1 mRNA, Tbx-5 mRNA, GATA4 mRNA , Flk-1 mRNA, GATA6 mRNA, Fog-1 mRNA, and combinations thereof, and/or have at least one polypeptide selected from the group consisting of Nkx2.5 polypeptides, MEF2C polypeptides, Tbx-5 polypeptides, MESP-1 polypeptides, GATA-4 polypeptides, FOG-2 polypeptides, and combinations thereof, wherein said polypeptide is associated with the nuclei of said cells.
Patent NZ-619314-A (NZ)
Title: Culture media for stem cells
Inventor: CLEVERS JOHANNES CAROLUS
IPC: C12N5/00
Filed: 2012-06-11
Abstract: Discloses a culture medium for expanding or differentiating a population of adult stem cells, wherein said culture medium comprises: i. an agonist of Lgr5; and ii. one or more TGF-beta inhibitor, wherein the inhibitor is a TGF-beta inhibitor if it can inhibit TGF-beta signalling in a cellular assay in which cells are stably transfected with a reporter construct comprising the human plasminogen activator inhibitor-1 (PAI-1) promoter.